These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 29621567)

  • 41. Relationship between leptin and regulatory T cells in systemic lupus erythematosus: preliminary results.
    Margiotta D; Navarini L; Vadacca M; Basta F; Lo Vullo M; Pignataro F; Zardi EM; Afeltra A
    Eur Rev Med Pharmacol Sci; 2016; 20(4):636-41. PubMed ID: 26957264
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Brief Report: Interleukin-38 Exerts Antiinflammatory Functions and Is Associated With Disease Activity in Systemic Lupus Erythematosus.
    Rudloff I; Godsell J; Nold-Petry CA; Harris J; Hoi A; Morand EF; Nold MF
    Arthritis Rheumatol; 2015 Dec; 67(12):3219-25. PubMed ID: 26314375
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Type I interferon and T helper 17 cells co-exist and co-regulate disease pathogenesis in lupus patients.
    Biswas PS; Aggarwal R; Levesque MC; Maers K; Ramani K
    Int J Rheum Dis; 2015 Jul; 18(6):646-53. PubMed ID: 25960196
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The prevalence and clinical significance of autoantibodies to plasminogen activator inhibitor 1 in systemic lupus erythematosus.
    Bates RL; Payne SJ; Drury SL; Nelson PN; Isenberg DA; Murphy JJ; Frampton G
    Lupus; 2003; 12(8):617-22. PubMed ID: 12945721
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Possible role of leptin in hypoandrogenicity in patients with systemic lupus erythematosus and rheumatoid arthritis.
    Härle P; Pongratz G; Weidler C; Büttner R; Schölmerich J; Straub RH
    Ann Rheum Dis; 2004 Jul; 63(7):809-16. PubMed ID: 15194576
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Matrix metalloproteinase 9 polymorphisms and systemic lupus erythematosus: correlation with systemic inflammatory markers and oxidative stress.
    Bahrehmand F; Vaisi-Raygani A; Kiani A; Rahimi Z; Tavilani H; Ardalan M; Vaisi-Raygani H; Shakiba E; Pourmotabbed T
    Lupus; 2015 May; 24(6):597-605. PubMed ID: 25416694
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pentraxin 3 as a biomarker of local inflammatory response to vascular injury in systemic lupus erythematosus.
    Cieślik P; Hrycek A
    Autoimmunity; 2015 Jun; 48(4):242-50. PubMed ID: 25401491
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Classification of Systemic Lupus Erythematosus: Systemic Lupus International Collaborating Clinics Versus American College of Rheumatology Criteria. A Comparative Study of 2,055 Patients From a Real-Life, International Systemic Lupus Erythematosus Cohort.
    Inês L; Silva C; Galindo M; López-Longo FJ; Terroso G; Romão VC; Rúa-Figueroa I; Santos MJ; Pego-Reigosa JM; Nero P; Cerqueira M; Duarte C; Miranda LC; Bernardes M; Gonçalves MJ; Mouriño-Rodriguez C; Araújo F; Raposo A; Barcelos A; Couto M; Abreu P; Otón-Sanchez T; Macieira C; Ramos F; Branco JC; Silva JA; Canhão H; Calvo-Alén J; ;
    Arthritis Care Res (Hoboken); 2015 Aug; 67(8):1180-5. PubMed ID: 25581417
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The -2518 A/G polymorphism in the monocyte chemoattractant protein 1 gene is associated with the risk of developing systemic lupus erythematosus in Argentinean patients: a multicenter study.
    Aranda F; Wingeyer SP; Muñoz SA; Allievi A; Orden A; Trobo R; Alvarez A; Eimon A; Barreira JC; Schneeberger E; Sarano J; Hofman J; de Larrañaga G
    Eur Cytokine Netw; 2012 Mar; 23(1):7-11. PubMed ID: 22466290
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Elevation of human tumor necrosis factor-like weak inducer of apoptosis in peripheral blood mononuclear cells is correlated with disease activity and lupus nephritis in patients with systemic lupus erythematosus.
    Liu ZC; Zhou QL; Li XZ; Yang JH; Ao X; Veeraragoo P; Zuo XX
    Cytokine; 2011 Mar; 53(3):295-300. PubMed ID: 21163672
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Leptin levels in patients with systemic lupus erythematosus inversely correlate with regulatory T cell frequency.
    Wang X; Qiao Y; Yang L; Song S; Han Y; Tian Y; Ding M; Jin H; Shao F; Liu A
    Lupus; 2017 Nov; 26(13):1401-1406. PubMed ID: 28409523
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluation of the alternative classification criteria of systemic lupus erythematosus established by Systemic Lupus International Collaborating Clinics (SLICC).
    Oku K; Atsumi T; Akiyama Y; Amano H; Azuma N; Bohgaki T; Asanuma YF; Horita T; Hosoya T; Ichinose K; Kato M; Katsumata Y; Kawaguchi Y; Kawakami A; Koga T; Kohsaka H; Kondo Y; Kubo K; Kuwana M; Mimori A; Mimori T; Mimura T; Murakami K; Nakano K; Nakayamada S; Ogishima H; Ohmura K; Saito K; Sano H; Shibuya M; Takahashi Y; Takasaki Y; Takeuchi T; Tamura N; Tanaka Y; Tsuboi H; Tsunoda S; Yukawa N; Yamakawa N; Yamamoto K; Sumida T
    Mod Rheumatol; 2018 Jul; 28(4):642-648. PubMed ID: 29120258
    [TBL] [Abstract][Full Text] [Related]  

  • 53. CXCL13 is an activity marker for systemic, but not cutaneous lupus erythematosus: a longitudinal cohort study.
    Niederkorn A; Frühauf J; Schwantzer G; Wutte N; Painsi C; Werner S; Stradner M; Berghold A; Hermann J; Aberer E
    Arch Dermatol Res; 2018 Aug; 310(6):485-493. PubMed ID: 29728857
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Serum 25-OH vitamin D level in treatment-naïve systemic lupus erythematosus patients: Relation to disease activity, IL-23 and IL-17.
    Shahin D; El-Farahaty RM; Houssen ME; Machaly SA; Sallam M; ElSaid TO; Neseem NO
    Lupus; 2017 Aug; 26(9):917-926. PubMed ID: 27927883
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Interleukin 1, interleukin 6, interleukin 10, and tumor necrosis factor α in active and quiescent systemic lupus erythematosus.
    Cigni A; Pileri PV; Faedda R; Gallo P; Sini A; Satta AE; Marras R; Carta E; Argiolas D; Rum I; Masala A
    J Investig Med; 2014 Jun; 62(5):825-9. PubMed ID: 24987977
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Raised plasma concentration and ex vivo production of inflammatory chemokines in patients with systemic lupus erythematosus.
    Lit LC; Wong CK; Tam LS; Li EK; Lam CW
    Ann Rheum Dis; 2006 Feb; 65(2):209-15. PubMed ID: 15975968
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Systemic low-grade inflammation is related to both circulating and adipose tissue TNFalpha, leptin and IL-6 levels in obese women.
    Maachi M; Piéroni L; Bruckert E; Jardel C; Fellahi S; Hainque B; Capeau J; Bastard JP
    Int J Obes Relat Metab Disord; 2004 Aug; 28(8):993-7. PubMed ID: 15211360
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Performance of the 2012 Systemic Lupus International Collaborating Clinics and the 1997 American College of Rheumatology classification criteria for systemic lupus erythematosus in a real-life scenario.
    Amezcua-Guerra LM; Higuera-Ortiz V; Arteaga-García U; Gallegos-Nava S; Hübbe-Tena C
    Arthritis Care Res (Hoboken); 2015 Mar; 67(3):437-41. PubMed ID: 25073545
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Increased serum matrix metalloproteinase 9 levels in systemic lupus erythematosus patients with neuropsychiatric manifestations and brain magnetic resonance imaging abnormalities.
    Ainiala H; Hietaharju A; Dastidar P; Loukkola J; Lehtimäki T; Peltola J; Korpela M; Heinonen T; Nikkari ST
    Arthritis Rheum; 2004 Mar; 50(3):858-65. PubMed ID: 15022328
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A role for TARC/CCL17, a CC chemokine, in systemic lupus erythematosus.
    Okamoto H; Koizumi K; Yamanaka H; Saito T; Kamatani N
    J Rheumatol; 2003 Nov; 30(11):2369-73. PubMed ID: 14677179
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.